Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 27, 2015 - Issue 6
310
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Development and application of a dosimetry model (ExDoM2) for calculating internal dose of specific particle-bound metals in the human body

&
Pages 308-320 | Received 27 Jan 2015, Accepted 23 Apr 2015, Published online: 01 Jun 2015
 

Abstract

The objective of the current study was to develop a dosimetry model (ExDoM2) for calculating internal dose of specific particle-bound metals (As, Pb, Cd, Cr and Mn) in the human body. The ExDoM2 is a revised version of a respiratory tract model (ExDoM) incorporating a new particle clearance mechanism in the respiratory tract model and a Physiologically-Based PharmacoKinetic (PBPK) model. The revised respiratory tract model was used to calculate the deposition, clearance and retention of particles in the human respiratory tract and the mass transferred to the oesophagus (gastrointestinal tract) and blood. The PBPK module was used to analyze the distribution of metals (As, Pb, Cd, Cr and Mn) from the blood circulation system to other organs or tissues like liver, kidneys, heart, brain, muscle and bone. The model was applied to calculate the internal human dose for an adult Caucasian male exposed to particulate mass matter (PM), PMPb, PMCd, PMMn and PMCr in an urban area (Athens, Greece). The analysis showed that at the end of the exposure (one day exposure scenario) to PMPb, the major accumulation occurs in the bone, blood and muscle, whereas as regards PMCd the major accumulation occurs in the other tissues, like kidney and liver. In addition, for PMMn, the major accumulation occurs in the other tissues and lungs, whereas as regards PMCr the major accumulation occurs in the gastrointestinal (GI) tract and lungs. Therefore, ExDoM2 is an important feature in studying deposition of particles in the human body.

Declaration of interest

The authors report no declarations of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.